Challenge area

NATO DIANA: Human Health & Performance

13 companies were selected under the Human Health & Performance challenge across the 2025 cohort, representing 6 countries.

Companies
13
Countries
6
Phase 2
3

Countries represented

All 13 companies

52 North Health

GB

United Kingdom · 2025 cohort

Develops portable sensors for acute radiation syndrome detection to support medical resilience.

Human Health & PerformancePhase 2

Belmont Diagnostics SAS

FR

France · 2025 cohort

Develops rapid diagnostic systems for point-of-care medical testing in austere environments.

Human Health & Performance

Cogitat

GB

United Kingdom · 2025 cohort

Imperial College London spin-out developing brain- computer interfaces to decode brain signals for pilot and surgical training.

Human Health & Performance

Flosonics Medical

CA

Canada · 2025 cohort

Develops wearable, wireless ultrasound devices for non-invasive cardiac monitoring in field settings.

Human Health & Performance

Gamma Pulse

FR

France · 2025 cohort

Develops pulsed electromagnetic field therapy devices for accelerating physical trauma recovery.

Human Health & Performance

Interact Medical Technologies

TR

Türkiye · 2025 cohort

Develops advanced medical training simulators for field medic preparation.

Human Health & Performance

MANITTY

FR

France · 2025 cohort

Develops wearable exoskeleton and assistive robotics to enhance soldier physical performance.

Human Health & PerformancePhase 2

Neuroverse

US

United States · 2025 cohort

Develops neurotechnology applications for cognitive enhancement in military contexts.

Human Health & Performance

Qidni Labs Inc.

CA

Canada · 2025 cohort

Develops wearable, portable dialysis technology for life- sustaining care in remote environments.

Human Health & Performance

QurieGen

NL

Netherlands · 2025 cohort

Develops genomic and biological tools for personalised health monitoring and performance optimisation.

Human Health & Performance

RealNose Inc

US

United States · 2025 cohort

Develops electronic nose technology for rapid detection of chemical and biological hazards.

Human Health & Performance

Sensible Biotechnologies

Country not publicly verified · 2025 cohort

Develops biosensor and biotechnology platforms for real-time health and environmental monitoring.

Human Health & Performance

Swaza

US

United States · 2025 cohort

Develops AI-powered decision support and medical triage tools for emergency and combat casualty care.

Human Health & PerformancePhase 2

Related challenge areas

Data reviewed 2026-08-23. Programme source: diana.nato.int. See the methodology.